Literature DB >> 17406481

Synthesis of non-natural ManNAc analogs for the expression of thiols on cell-surface sialic acids.

Srinivasa-Gopalan Sampathkumar1, Adrienne V Li, Kevin J Yarema.   

Abstract

The sialic acid biosynthetic pathway in mammalian cells utilizes N-acetyl-D-mannosamine (ManNAc) as a natural metabolic precursor and has the remarkable ability to biosynthetically process non-natural ManNAc analogs. Herein, we describe a recipe-style protocol for the synthesis of the novel peracetylated analog Ac5ManNTGc (1) that contains a pendant acetylthio- group and enables incorporation of thiol functionalities into the glycocalyx of living cells. We also describe the synthesis of the oxygen analog Ac5ManNGc (2), which serves as an appropriate control compound for biological experiments with 1. Both 1 and 2 were prepared from a reported, common intermediate 8, which is selectively acetylated at the hydroxyl groups. In contrast to previous methods, this synthetic approach introduces O-acetyl groups first, followed by N-acylation. Starting from the commercially available D-mannosamine hydrochloride (5), gram quantities of both 1 and 2 can be prepared over five steps in about 2-3 weeks.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17406481     DOI: 10.1038/nprot.2006.319

Source DB:  PubMed          Journal:  Nat Protoc        ISSN: 1750-2799            Impact factor:   13.491


  15 in total

1.  Chemical control of metabolically-engineered voltage-gated K+ channels.

Authors:  Zhengmao Hua; Anatoli Lvov; Trevor J Morin; William R Kobertz
Journal:  Bioorg Med Chem Lett       Date:  2011-04-28       Impact factor: 2.823

2.  Experimental Design Considerations for In Vitro Non-Natural Glycan Display via Metabolic Oligosaccharide Engineering.

Authors:  Elaine Tan; Ruben T Almaraz; Hargun S Khanna; Jian Du; Kevin J Yarema
Journal:  Curr Protoc Chem Biol       Date:  2010-09-01

Review 3.  Carbohydrate engineered cells for regenerative medicine.

Authors:  Jian Du; Kevin J Yarema
Journal:  Adv Drug Deliv Rev       Date:  2010-02-01       Impact factor: 15.470

4.  Deciphering glycan linkages involved in Jurkat cell interactions with gold-coated nanofibers via sugar-displayed thiols.

Authors:  Jian Du; Pao-Lin Che; Udayanath Aich; Elaine Tan; Hyo Jun Kim; Srinivasa-Gopalan Sampathkumar; Kevin J Yarema
Journal:  Bioorg Med Chem Lett       Date:  2011-05-19       Impact factor: 2.823

5.  Designing a binding interface for control of cancer cell adhesion via 3D topography and metabolic oligosaccharide engineering.

Authors:  Jian Du; Pao-Lin Che; Zhi-Yun Wang; Udayanath Aich; Kevin J Yarema
Journal:  Biomaterials       Date:  2011-05-05       Impact factor: 12.479

6.  Metabolic monosaccharides altered cell responses to anticancer drugs.

Authors:  Long Chen; Jun F Liang
Journal:  Eur J Pharm Biopharm       Date:  2012-04-02       Impact factor: 5.571

7.  Glycoengineering human neural stem cells (hNSCs) for adhesion improvement using a novel thiol-modified N-acetylmannosamine (ManNAc) analog.

Authors:  Jian Du; Xiao Liu; Kevin J Yarema; Xiaofeng Jia
Journal:  Biomater Adv       Date:  2022-01-21

8.  An Augmented Method for Collecting PLGA Nanoparticles and the Fabrication of 1, 3, 4, 6-Tetra-O-acetyl-2-azido-2-deoxy-D-glucopyranose (Ac42AzGlc)-Loaded PLGA Nanoparticles for Efficient and Prospective in Vivo Metabolic Processing.

Authors:  Shubham Parashar; Charu Chauhan; Abhiraj Rajasekharan; Jyoti Rautela; Tanya Jain; Kaisar Raza
Journal:  Front Bioeng Biotechnol       Date:  2022-06-27

9.  Hexosamine template. A platform for modulating gene expression and for sugar-based drug discovery.

Authors:  Noha Elmouelhi; Udayanath Aich; Venkata D P Paruchuri; M Adam Meledeo; Christopher T Campbell; Jean J Wang; Raja Srinivas; Hargun S Khanna; Kevin J Yarema
Journal:  J Med Chem       Date:  2009-04-23       Impact factor: 7.446

Review 10.  Metabolic glycoengineering: sialic acid and beyond.

Authors:  Jian Du; M Adam Meledeo; Zhiyun Wang; Hargun S Khanna; Venkata D P Paruchuri; Kevin J Yarema
Journal:  Glycobiology       Date:  2009-08-12       Impact factor: 4.313

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.